Protein Intake, Metabolic Status and the Gut Microbiota in Different Ethnicities: Results from Two Independent Cohorts.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
10 Sep 2021
Historique:
received: 02 08 2021
revised: 18 08 2021
accepted: 27 08 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 16 11 2021
Statut: epublish

Résumé

Protein intake has been associated with the development of pre-diabetes (pre-T2D) and type 2 diabetes (T2D). The gut microbiota has the capacity to produce harmful metabolites derived from dietary protein. Furthermore, both the gut microbiota composition and metabolic status (e.g., insulin resistance) can be modulated by diet and ethnicity. However, to date most studies have predominantly focused on carbohydrate and fiber intake with regards to metabolic status and gut microbiota composition. To determine the associations between dietary protein intake, gut microbiota composition, and metabolic status in different ethnicities. Separate cross-sectional analysis of two European cohorts (MetaCardis, In both cohorts, animal (but not plant) protein intake was associated with pre-T2D status and T2D status after adjustment for confounders. There was no significant association between protein intake (total, animal, or plant) with either gut microbiota alpha diversity or beta diversity, regardless of ethnicity. At the species level, we identified taxonomical signatures associated with animal protein intake that overlapped in both cohorts with different abundances according to metabolic status and ethnicity. Animal protein intake is associated with pre-T2D and T2D status but not with gut microbiota beta or alpha diversity, regardless of ethnicity. Gut microbial taxonomical signatures were identified, which could function as potential modulators in the association between dietary protein intake and metabolic status.

Sections du résumé

BACKGROUND BACKGROUND
Protein intake has been associated with the development of pre-diabetes (pre-T2D) and type 2 diabetes (T2D). The gut microbiota has the capacity to produce harmful metabolites derived from dietary protein. Furthermore, both the gut microbiota composition and metabolic status (e.g., insulin resistance) can be modulated by diet and ethnicity. However, to date most studies have predominantly focused on carbohydrate and fiber intake with regards to metabolic status and gut microbiota composition.
OBJECTIVES OBJECTIVE
To determine the associations between dietary protein intake, gut microbiota composition, and metabolic status in different ethnicities.
METHODS METHODS
Separate cross-sectional analysis of two European cohorts (MetaCardis,
RESULTS RESULTS
In both cohorts, animal (but not plant) protein intake was associated with pre-T2D status and T2D status after adjustment for confounders. There was no significant association between protein intake (total, animal, or plant) with either gut microbiota alpha diversity or beta diversity, regardless of ethnicity. At the species level, we identified taxonomical signatures associated with animal protein intake that overlapped in both cohorts with different abundances according to metabolic status and ethnicity.
CONCLUSIONS CONCLUSIONS
Animal protein intake is associated with pre-T2D and T2D status but not with gut microbiota beta or alpha diversity, regardless of ethnicity. Gut microbial taxonomical signatures were identified, which could function as potential modulators in the association between dietary protein intake and metabolic status.

Identifiants

pubmed: 34579043
pii: nu13093159
doi: 10.3390/nu13093159
pmc: PMC8465773
pii:
doi:

Substances chimiques

DNA, Bacterial 0
Dietary Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fondation Leducq
ID : 33.17CVD01
Organisme : Joint Programming Initiative A healthy diet for a healthy life
ID : 5290510105
Organisme : ZonMw
ID : 09150182010020
Pays : Netherlands
Organisme : Fondation pour la Recherche Médicale
ID : FDT202106012793

Références

Nutrients. 2020 Oct 23;12(11):
pubmed: 33113929
Gut. 2019 Aug;68(8):1417-1429
pubmed: 30782617
Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):65-71
pubmed: 28539866
Sci Rep. 2020 Mar 25;10(1):5450
pubmed: 32214153
BMJ Open. 2017 Dec 14;7(12):e017873
pubmed: 29247091
Br J Nutr. 2016 Dec;116(11):1869-1877
pubmed: 27974055
JAMA Intern Med. 2016 Oct 1;176(10):1453-1463
pubmed: 27479196
Proc Natl Acad Sci U S A. 1918 Dec;4(12):370-3
pubmed: 16576330
Cell Host Microbe. 2019 Mar 13;25(3):444-453.e3
pubmed: 30799264
Nat Biotechnol. 2014 Aug;32(8):834-41
pubmed: 24997786
Science. 2016 Apr 29;352(6285):560-4
pubmed: 27126039
Annu Rev Med. 2020 Jan 27;71:149-161
pubmed: 31479620
Am J Clin Nutr. 2018 Aug 1;108(2):405-413
pubmed: 29931213
Nat Med. 2018 Oct;24(10):1526-1531
pubmed: 30150717
Eur J Nutr. 2021 Sep;60(6):3279-3301
pubmed: 33591390
Genome Biol. 2020 Aug 3;21(1):192
pubmed: 32746938
Nat Commun. 2020 Nov 18;11(1):5881
pubmed: 33208748
PLoS Biol. 2018 Dec 4;16(12):e2006842
pubmed: 30513082
J Epidemiol Glob Health. 2020 Mar;10(1):107-111
pubmed: 32175717
Acta Diabetol. 2019 Aug;56(8):851-870
pubmed: 30929078
Ethn Health. 2009 Jun;14(3):255-69
pubmed: 19052941
Am J Clin Nutr. 2010 Jan;91(1):106-14
pubmed: 19889820
Open Heart. 2019 Feb 27;6(1):e000890
pubmed: 30997120
Nutrients. 2017 Sep 06;9(9):
pubmed: 28878172
Nature. 2014 Jan 23;505(7484):559-63
pubmed: 24336217
Clin Nutr. 2020 Jan;39(1):242-249
pubmed: 30739809
Cell. 2018 Nov 1;175(4):947-961.e17
pubmed: 30401435
J Acad Nutr Diet. 2017 Jun;117(6):878-888
pubmed: 28024800
Microb Cell Fact. 2020 Mar 6;19(1):61
pubmed: 32143621
Science. 2016 Apr 29;352(6285):565-9
pubmed: 27126040
Gut Microbes. 2020 Nov 1;11(6):1632-1642
pubmed: 32576065
PLoS One. 2019 Dec 31;14(12):e0226372
pubmed: 31891582
Cell Metab. 2009 Apr;9(4):311-26
pubmed: 19356713
EBioMedicine. 2020 Jan;51:102590
pubmed: 31901868
Mol Metab. 2021 Apr;46:101158
pubmed: 33387681
BMC Public Health. 2011 Jun 07;11:441
pubmed: 21649889
Future Microbiol. 2015;10(9):1485-504
pubmed: 26347019
Nat Med. 2011 Apr;17(4):448-53
pubmed: 21423183
Diabetes Care. 2010 Oct;33(10):2277-84
pubmed: 20876708
Gut Microbes. 2018;9(3):189-201
pubmed: 29144833
Curr Diab Rep. 2020 Nov 20;20(12):73
pubmed: 33216289
Genome Announc. 2015 Nov 05;3(6):
pubmed: 26543119
Diabetes Care. 2014 Jan;37 Suppl 1:S14-80
pubmed: 24357209
Am J Clin Nutr. 1997 Apr;65(4 Suppl):1220S-1228S; discussion 1229S-1231S
pubmed: 9094926
Nat Commun. 2018 Jul 18;9(1):2802
pubmed: 30022049
Gut. 2020 Jul;69(7):1218-1228
pubmed: 32066625
World J Gastroenterol. 2011 Mar 28;17(12):1519-28
pubmed: 21472114
Diabetes Care. 2012 Jul;35(7):1499-505
pubmed: 22596177
Science. 2018 Mar 9;359(6380):1151-1156
pubmed: 29590046
N Engl J Med. 2013 Apr 25;368(17):1575-84
pubmed: 23614584

Auteurs

Pierre Bel Lassen (P)

Nutrition and Obesities, Systemic Approaches (NutriOmics) Research Group, INSERM, Sorbonne Université, 75013 Paris, France.
Center for Research on Human Nutrition Ile-de-France (CRNH IdF), Nutrition Department, Assistance Publique Hôpitaux de Paris, Pitie-Salpêtrière Hospital, 75013 Paris, France.

Ilias Attaye (I)

Department of Internal Medicine and Vascular Medicine, Amsterdam University Medical Center, Location Academic Medical Center, 1105 Amsterdam, The Netherlands.
Department of Experimental Vascular Medicine, Amsterdam University Medical Center, Location Academic Medical Center, 1105 Amsterdam, The Netherlands.

Solia Adriouch (S)

Nutrition and Obesities, Systemic Approaches (NutriOmics) Research Group, INSERM, Sorbonne Université, 75013 Paris, France.

Mary Nicolaou (M)

Department of Public and Occupational Health, Amsterdam University Medical Center, Location Academic Medical Center, 1105 Amsterdam, The Netherlands.

Judith Aron-Wisnewsky (J)

Nutrition and Obesities, Systemic Approaches (NutriOmics) Research Group, INSERM, Sorbonne Université, 75013 Paris, France.
Center for Research on Human Nutrition Ile-de-France (CRNH IdF), Nutrition Department, Assistance Publique Hôpitaux de Paris, Pitie-Salpêtrière Hospital, 75013 Paris, France.

Trine Nielsen (T)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 1162 Copenhagen, Denmark.

Rima Chakaroun (R)

Medical Department III-Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, 04109 Leipzig, Germany.

Emmanuelle Le Chatelier (E)

MetaGenoPolis, INRAE (Institut National de Recherche Pour L'agriculture, L'alimentation et L'environnement), University Paris-Saclay, 78350 Jouy-en-Josas, France.

Sofia Forslund (S)

Experimental and Clinical Research Center, a Cooperation of Charité-Universitätsmedizin and the Max-Delbrück Center, 10117 Berlin, Germany.

Eugeni Belda (E)

Integrative Phenomics, 75011 Paris, France.

Peer Bork (P)

Structural and Computational Biology, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.

Fredrik Bäckhed (F)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 1162 Copenhagen, Denmark.
Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, 41345 Gothenburg, Sweden.
Department of Clinical Physiology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.

Michael Stumvoll (M)

Medical Department III-Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, 04109 Leipzig, Germany.

Oluf Pedersen (O)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 1162 Copenhagen, Denmark.

Hilde Herrema (H)

Department of Internal Medicine and Vascular Medicine, Amsterdam University Medical Center, Location Academic Medical Center, 1105 Amsterdam, The Netherlands.
Department of Experimental Vascular Medicine, Amsterdam University Medical Center, Location Academic Medical Center, 1105 Amsterdam, The Netherlands.

Albert K Groen (AK)

Department of Internal Medicine and Vascular Medicine, Amsterdam University Medical Center, Location Academic Medical Center, 1105 Amsterdam, The Netherlands.
Department of Experimental Vascular Medicine, Amsterdam University Medical Center, Location Academic Medical Center, 1105 Amsterdam, The Netherlands.

Sara-Joan Pinto-Sietsma (SJ)

Department of Internal Medicine and Vascular Medicine, Amsterdam University Medical Center, Location Academic Medical Center, 1105 Amsterdam, The Netherlands.
Department of Clinical Epidemiology, Biostatistics and Bio-Informatics, Amsterdam University Medical Center, Location Academic Medical Center, 1105 Amsterdam, The Netherlands.

Aeilko H Zwinderman (AH)

Department of Clinical Epidemiology, Biostatistics and Bio-Informatics, Amsterdam University Medical Center, Location Academic Medical Center, 1105 Amsterdam, The Netherlands.

Max Nieuwdorp (M)

Department of Internal Medicine and Vascular Medicine, Amsterdam University Medical Center, Location Academic Medical Center, 1105 Amsterdam, The Netherlands.
Department of Experimental Vascular Medicine, Amsterdam University Medical Center, Location Academic Medical Center, 1105 Amsterdam, The Netherlands.
Department of Internal Medicine, Diabetes Center, Amsterdam University Medical Center, Location VU University Medical Center, 1105 Amsterdam, The Netherlands.

Karine Clement (K)

Nutrition and Obesities, Systemic Approaches (NutriOmics) Research Group, INSERM, Sorbonne Université, 75013 Paris, France.
Center for Research on Human Nutrition Ile-de-France (CRNH IdF), Nutrition Department, Assistance Publique Hôpitaux de Paris, Pitie-Salpêtrière Hospital, 75013 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH